Welcome to the home of Speer Medical Technologies, a biotechnology company developing medications and therapies for patients lacking a diverse selection of effective cancer treatment options. We utilize our proprietary technology to refine and enhance targeted radionuclide therapies and cancer medications to target and stop the spread of harmful cancerous cells.

Combining our years of research in the field of clinical oncology, physics and biology, Speer Medical Technologies has an ongoing mission of developing a broad selection of targeted radiopharmaceuticals and medications for various types of cancer. Our ultimate quest is the development of a platform for the production of a patient specific cancer therapeutic.